Grace, R. F., Glenthoj, A., Barcellini, W., Verhovsek, M., Rothman, J. A., Morado, A. M., … Al-Samkari, H. (2022). Sustained effect on hemoglobin levels and reduced transfusion burden maintained in patients with pyruvate kinase deficiency on mitapivat in a long-term extension study. In ONCOLOGY RESEARCH AND TREATMENT (Vol. 45, pp. 138–139).

Grace, R. F., A. Glenthoj, W. Barcellini, M. Verhovsek, J. A. Rothman, Arias M. Morado, D. M. Layton, et al. “Sustained effect on hemoglobin levels and reduced transfusion burden maintained in patients with pyruvate kinase deficiency on mitapivat in a long-term extension study.” In ONCOLOGY RESEARCH AND TREATMENT, 45:138–39, 2022.

Grace RF, Glenthoj A, Barcellini W, Verhovsek M, Rothman JA, Morado AM, et al. Sustained effect on hemoglobin levels and reduced transfusion burden maintained in patients with pyruvate kinase deficiency on mitapivat in a long-term extension study. In: ONCOLOGY RESEARCH AND TREATMENT. 2022. p. 138–9.

Grace, R. F., et al. “Sustained effect on hemoglobin levels and reduced transfusion burden maintained in patients with pyruvate kinase deficiency on mitapivat in a long-term extension study.” ONCOLOGY RESEARCH AND TREATMENT, vol. 45, no. SUPPL 2, 2022, pp. 138–39.

Grace RF, Glenthoj A, Barcellini W, Verhovsek M, Rothman JA, Morado AM, Layton DM, Andres O, Galacteros F, van Beers EJ, Onodera K, Viprakasit V, Chonat S, Porter JB, Judge MP, Kosinski PA, Hawkins P, Gheuens S, Xu R, Mcgee B, Beynon V, Al-Samkari H. Sustained effect on hemoglobin levels and reduced transfusion burden maintained in patients with pyruvate kinase deficiency on mitapivat in a long-term extension study. ONCOLOGY RESEARCH AND TREATMENT. 2022. p. 138–139.